Targeting of AML-leukemic stem cells with monoclonal antibodies

ISSN： 1479-6694

Source： Future Oncology, Vol.5, Iss.9, 2009-11, pp. : 1327-1330

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Leukemic Stem Cells: A Review

By O'Brien J. A.

Cancer Investigation, Vol. 31, Iss. 4, 2013-05 ,pp. : 215-220

Informa Healthcare

Access to resources Recommend Favorite

Runx1/AML1 is a Guardian of Hematopoietic Stem Cells

Current Cancer Therapy Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. : 188-195

Bentham Science Publishers

Access to resources Recommend Favorite

Targeting Prostate Cancer Stem Cells

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 9, Iss. 10, 2009-12 ,pp. : 1105-1113

Bentham Science Publishers

Access to resources Recommend Favorite

Normal and leukemic human stem cells assayed in SCID mice

By Dick J.E.

Seminars in Immunology, Vol. 8, Iss. 4, 1996-04 ,pp. : 197-206

Academic Press

Access to resources Recommend Favorite

The Molecular Bases of the Self-Renewal and Differentiation of Leukemic Stem Cells

Current Cancer Therapy Reviews, Vol. 4, Iss. 3, 2008-08 ,pp. : 178-187

Bentham Science Publishers

Access to resources Recommend Favorite